• Home
  • News
    • People moves
    • Africa
    • Asia
    • Australia
    • Canada
    • Caribbean
    • Domicile
    • Europe
    • Latin America
    • North America
    • Middle East
    • US
    • US
    • UK
  • Products
    • Funds
    • Pensions
    • Platforms
    • Insurance
    • Investments
    • Private Banking
    • Citizenship
    • Taxation
  • Fintech
  • Regulation
  • ESG
  • Expats
  • In Depth
  • Special Reports
  • Directory
  • Video
  • Advertise with us
  • Directory
  • Events
  • European Fund Selector
  • Newsletters
  • Follow us
    • Twitter
    • LinkedIn
    • Newsletters
  • Advertise with us
  • Directory
  • Events
    • Upcoming events
      event logo
      International Investment Nordic Forum 2021

      International Investment is delighted to announce the 2021 International Investment Nordic Forum which will take place on Tuesday March 9, at 9am (GMT). This curated virtual event will be broadcast live and will feature a series of fund manager interviews and presentations, as well as interviews with some of the Nordic regions top fund selectors.

      • Date: 09 Mar 2021
      • ONLINE, ONLINE
      event logo
      Sustainable Investment Festival 2021

      The Sustainable Investment Festival will run online from 22-25 June and will include thought-provoking presentations from renowned keynote speakers, innovative breakout events and sessions specifically tailored to meet the information needs of fund selectors, financial advisers, pension consultants, trustees and scheme managers.

      • Date: 22 Jun 2021
      • Online, Online
      View all events
  • European Fund Selector
International Investment
International Investment

Sponsored by

Sharing Alpha
  • Home
  • News
  • Products
  • Fintech
  • Regulation
  • ESG
  • Expats
  • In Depth
  • Special Reports
  • Video

Polar Capital launches biotechnology fund

  • Viola Caon
  • 01 November 2013
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Send to  

Polar Capital Holdings has announced the launch of an open-ended Ucits global biotechnology fund.

Polar Capital Holdings has announced the launch of an open-ended Ucits global biotechnology fund.

The open-ended Ucits vehicle will be managed by David Pinniger, a recent hire into Polar Capital’s specialist healthcare investment team, and is the latest addition to the firm’s existing healthcare investment strategies.

Related articles

  • Polar Capital launches biotechnology Ucits
  • S&G healthcare fund opens to European investors
  • Janus Henderson Investors launches horizon biotechnology fund
  • Biotechnology is key to returns amid growing populations

The investment objective of the Polar Capital Biotechnology Fund will be to achieve long-term capital growth by investing in a globally diversified portfolio of biotechnology companies. The manager will use a fundamental research-driven approach to construct a portfolio of between 40 and 60 investments, with performance benchmarked against the NASDAQ Biotechnology Index.

The fund is available in sterling, US dollar and euro-denominated share classes. The annual management charge is 1.5% on the retail share class and 1.0% on the institutional share class.

David Pinniger commented: “We believe the global biotechnology industry is poised to deliver significant value creation over the coming years driven by a major new innovation cycle. It is our view that the sector’s stock market resurgence in recent years could be just the start of a multi-year re-rating as this high growth global industry comes of age.

“We intend to create an actively managed portfolio of what we believe to be the highest quality opportunities in the field of biotechnology-driven medical innovation. Investments will be made in companies where we believe the successful development of a drug, device or diagnostic has the potential to transform the treatment of a disease where there is real unmet medical need.

Gareth Powell, co-manager of the team’s Healthcare Opportunities Fund, added: “We are very excited about the launch of the biotechnology fund. It will provide investors with actively managed exposure to one of the global economy’s most exciting growth industries, in an environment where high quality growth opportunities are scarce. David has ideal experience of managing a long equity strategy in this global industry and a strong track record, and will be supported by the specialist healthcare team here at Polar Capital.”

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Send to  
  • Topics
  • UK
  • Distribution
  • Polar Capital
  • Undertakings for Collective Investment in Transferable Securities (Ucits)
  • United Kingdom
Back to Top

Most read

Global UHNWI population to grow by 27% over the next five years: Knight Frank
Global UHNWI population to grow by 27% over the next five years: Knight Frank
Amati Global Investors launches strategic metals fund
Amati Global Investors launches strategic metals fund
Aviva announces exit from Turkey
Aviva announces exit from Turkey
HSBC Malaysia appoints head of global banking
HSBC Malaysia appoints head of global banking
Erratic Bitcoin leaves industry divided as Square invests $170m
Erratic Bitcoin leaves industry divided as Square invests $170m
  • Contact Us
  • Marketing solutions
  • About Incisive Media
  • Terms and conditions
  • Policies
  • Careers
  • Twitter
  • LinkedIn
  • Newsletters

© Incisive Business Media (IP) Limited, Published by Incisive Business Media Limited, New London House, 172 Drury Lane, London WC2B 5QR, registered in England and Wales with company registration numbers 09177174 & 09178013

Digital publisher of the year
Digital publisher of the year 2010, 2013, 2016 & 2017
Loading